News|Videos|February 11, 2025

Drug prices: Another way to interpret negotiations for cost

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

Under the administration of President Joe Biden, there were a number of provisions beneficial to senior patients through the Inflation Reduction Act. The Alliance for Aging Research (AAR) supports those, said Adina Lasser AAR director of public policy and government affairs. But there is a nuance: the Medicare Drug Price Negotiation Program has no mechanism for passing along savings to beneficiaries at the pharmacy counter.


Related to this article

Why is healthcare spending declining in 2026? ©Kuzmick - stock.adobe.com
Health care was the only one of five sectors to cut spending commitments this spring, falling 2.8% as hospitals faced rising supply costs and physicians awaited the final 2027 Medicare fee schedule, Coupa's Business Spend Index found.